Sorrento Therapeutics Inc. (SRNE): Wildcat Capital Management Ups Its Stake and Reiterates Demands

Page 11 of 15

Page 11 of 15 – SEC Filing
5. Letter to the Board of Directors of the Issuer, dated May 10, 2016.

Page 11 of 15 Pages

Follow Sorrento Therapeutics Inc. (NASDAQ:SRNEQ)

Page 11 of 15